Replies to post #4242 on Relief Therapeutics Holding AG (RLFTF)

[Andy2018]

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)

Experimental: Aviptadil IV in escalating doses + standard of care
Patients will be administered Aviptadil IV in escalating doses of 50 pmol, 100 pmol, 150 pmol/kg/hr

https://clinicaltrials.gov/ct2/show/NCT04311697?term=Aviptadil&draw=1&rank=1